Skip to main content

Table 4 Reducing effect of EAA/KA on GFR slope decrease: the results of uni-variate analysis, categorical variable comparison and variables in final multi-variate model

From: Efficacy of the Essential Amino Acids and Keto-Analogues on the CKD progression rate in real practice in Russia - city nephrology registry data for outpatient clinic

 

Uni-variate analysis

Final model of multi-variate analysisb

Variable

Unstandardized B

p

95 % CI for B

Unstandardized B

p

95 % CI for B

Age (per 10 year)

0.023

0.08

−0.004 ÷ 0.05

0.021

0.06

−0.002 ÷ 0.04

PU mean (per 1 g/day)

−0.061

0.08

−0.13 ÷ 0.09

−0.065

0.06

−0.14 ÷ 0.005

PU max (per 1 g/day)

−0.023

0.38

−0.004 ÷ 0.05

Albumin (per 0.1 g/dl)

−0.061

0.21

−0.04 ÷ 0.16

Phosphate (per 0.1 mmol/l)

0.015

0.18

−0.008 ÷ 0.04

0.016

0.08

−0.003 ÷ 0.03

Hb (per 1 g/dl)

0.018

0.32

−0.02 ÷ 0.06

ln CRP (per 0.1 mg/dla)

−0.039

0.14

−0.09 ÷ 0.15

Categorical variable comparisons

Categorical variable in equation

 Glom. v. interst.

−0.082 ± 0.035

0.06

−0.059 ± 0.044

−0.016

0.06

−0.003 ÷ 0.03

 Female v. male

−0.079 ± 0.025

0.11

−0.066 ± 0.024

−0.013

0.03

−0.003 ÷ − 0.001

 DM v. non-DM

−0.072 ± 0.021

0.50

−0.069 ± 0.023

  1. CI confidence interval, PU proteinuria, g/day, mean averaged for study period, max maximum per study period, Hb hemoglobin, CRP C-reactive protein, glom. glomerular diseases, interst. interstitial diseases, DM diabetes mellitus
  2. aBefore ln-transformation
  3. bp for exclusion from model 0.10